Annals of the New York Academy of Sciences · 2004 · 78 citations · 18 references
MedicineEndocrinologyPsychiatryNeuroendocrinologyNeuropsychiatrySteroid BiochemistryAdrenal Steroid HormonesAndrogen PhysiologyHormonal InfluencesMental IllnessSchizophrenia Spectrum DisordersAdrenal Androgen ProductionAdrenal AndrogensAndrogen ProfileHormonal AlterationsPilot Study Design
We conducted a pilot study in 10 adult male schizophrenics, 5 with predominantly positive symptoms (group I) and 5 with predominantly negative symptoms (group II), and 10 healthy matched controls. No significant differences in serum levels of testosterone (T), dehydroepiandrosterone sulfate (DHEAS), estradiol, and cortisol were found between patients as a whole and controls, using radioimmunoassay. However, serum T and DHEAS levels were lower (P <0.05) in group II patients than in group I. Body hair and aggression scores also were lower (P <0.05) in group II. In a much larger sample, Shirayama and colleagues also showed that "moderate negative symptoms, but not low negative symptoms" correlated negatively with T (P <0.05), but positively with ACTH (P <0.05) and cortisol (P <0.01) levels in plasma. Neuroactive steroids, such as DHEAS, and other sex hormones, including their synthetic derivatives, may have an adjunctive role in reversing or slowing the progression of negative symptoms. Indeed, "DHEA augmentation" improved "negative (P <0.01), depressive (P <0.05), and anxiety (P <0.01) symptoms."
18
Altered salivary dehydroepiandrosterone levels in major depression in adults
Albert Michael, Alison Jenaway, Eugene S. Paykel et al. · Biological Psychiatry · 2000 · 205 citations
Medicine, Pharmacology, Psychiatry +11